Arcturus Therapeutics Holdings (ARCT) Free Cash Flow Growth (1y) (2019 - 2026)
Arcturus Therapeutics Holdings (ARCT) Free Cash Flow Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 60.84% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 88.70% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.72% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 66.37% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - | 44.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.89% |
| Dec 31, 2025 | -5,664.08% |
| Sep 30, 2025 | 28.28% |
| Jun 30, 2025 | 81.11% |
| Mar 31, 2025 | -508.50% |
| Dec 31, 2024 | 81.12% |
| Sep 30, 2024 | 29.57% |
| Jun 30, 2024 | -160.53% |
| Mar 31, 2024 | 83.89% |
| Dec 31, 2023 | -100.96% |
| Sep 30, 2023 | 24.08% |
| Jun 30, 2023 | 238.13% |
| Mar 31, 2023 | 29.66% |
| Dec 31, 2022 | 488.58% |
| Sep 30, 2022 | -142.10% |
| Jun 30, 2022 | -9.68% |
| Mar 31, 2022 | -18.44% |
| Dec 31, 2021 | -599.48% |
| Sep 30, 2021 | -9.13% |
| Jun 30, 2021 | -295.75% |